Perfil
Mark-Andre Freyberg is the founder of Dermatools Biotech GmbH (founded in 2004), Cytopharma GmbH (founded in 2006), and bioXXmed AG (founded in 2000).
At bioXXmed AG, he held the title of Chief Executive Officer from 2000 to 2021.
Dr. Freyberg's former jobs include Chief Executive Officer at TemplaTech GmbH and Project Manager at Technische Universität Darmstadt.
He earned a doctorate degree from Technische Universität Darmstadt.
Antiguos cargos conocidos de Mark-Andre Freyberg.
| Empresas | Cargo | Fin |
|---|---|---|
| BIOXXMED AG | Director Ejecutivo | 30/09/2021 |
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology Develops biological medical products | Presidente | 03/09/2007 |
Dermatools Biotech GmbH
Dermatools Biotech GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the field of natural sciences, engineering, agricultural sciences and medicine | Fundador | - |
Cytopharma GmbH | Fundador | - |
Technische Universität Darmstadt
Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formación de Mark-Andre Freyberg.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Technische Universität Darmstadt
Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bioXXmed AG
bioXXmed AG Pharmaceuticals: MajorHealth Technology Manufactures active ingredients | Health Technology |
TemplaTech GmbH
TemplaTech GmbH BiotechnologyHealth Technology Develops biological medical products | Health Technology |
Dermatools Biotech GmbH
Dermatools Biotech GmbH Miscellaneous Commercial ServicesCommercial Services Engages in research and development in the field of natural sciences, engineering, agricultural sciences and medicine | Commercial Services |
Cytopharma GmbH |
- Bolsa de valores
- Insiders
- Mark-Andre Freyberg
















